The impact of diabetes mellitus on the mortality of acute coronary syndromes;Impacto do diabetes mellitus na mortalidade em síndromes coronarianas agudas

Arquivos Brasileiros de Endocrinologia e Metabologia

Volumn 51, Issue 2, 2007, Pages 275-280

  De Braga, Juarez R ^a   Santos, Ítalo S O ^a   Flato, Uri P ^a   Guimarães, Hélio P ^a   Avezum, Álvaro ^a,b  

^a INSTITUTO DANTE PAZZANESE DE CARDIOLOGIA   (Brazil)

^b NONE   (Brazil)

Author keywords

Cardiovascular diseases; Diabetes mellitus; Evidence based medicine; Mortality

Indexed keywords

EID: 34248582659     PISSN: 00042730     EISSN: 16779487     Source Type: Journal    
DOI: 10.1590/s0004-27302007000200016     Document Type: Review

References (45)

1. Roglic G, Unwin N, Bennett P, Mathers C, Tuomilehto J, Nag S, et al. The burden of mortality attributable to diabetes: realistic estimates for the year 2000. Diabetes Care 2005;28:2130-5.
2. Haffner SM, Lehto S, Rönnemaa T, Pyörälä K, Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 1998;339(4):229-34.
3. Yusuf S, Hawken S, Ôunpuu S, Dans T, Avezum A, Lanas F, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 2004;364:937-52.
4. Piegas LS, Avezum A, Pereira JCR, Rossi Neto JM, Hoepfner C, Farran JA, et al.; on behalf of the AFIRMAR study investigators. Risk factors for myocardial infarction in Brazil. Am Heart J 2003;146:331-8.
5. Franklin K, Goldberg RJ, Spencer F, Klein W, Budaj A, Brieger D. Implications of diabetes in patients with acute coronary syndromes. The global registry of acute coronary events. Arch Intern Med 2004;164:1457-63.
6. Aronson D, Rayfield EJ, Chesebro JH. Mechanisms determining course and outcome of diabetic patients who have had acute myocardial infarction. Ann Intern Med 1997;126:296-306.
7. Berger AK, Breall JA, Gersh BJ, Johnson AE, Oetgen WJ, Marciniak TA, et al. Effect of diabetes mellitus and insulin use on survival after acute myocardial infarction in the elderly (The Cooperative Cardiovascular Project). Am J Cardiol 2001;87:272-7.
8. Brunner EJ, Shipley MJ, Witte DR, Fuller JH, Marmot MG. Relation between blood glucose and coronary mortality over 33 years in the Whitehall Study. Diabetes Care 2006;29:26-31.
9. Coutinho M, Gerstein HC, Wang Y, Yusuf S. The relationship between glucose and incident cardiovascular events. A meta regression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years. Diabetes Care 1999;22:233-40.
10. Gu K, Cowie CC, Harris MI. Diabetes and decline in heart disease mortality in US adults. JAMA 1999;281:1291-7.
11. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for 2030. Diabetes Care 2004;27:1047-53.
12. Bartnik M, Malmberg K, Rydén L. Management of patients with type 2 diabetes after acute coronary syndromes. Diabetes Vasc Dis Res 2005;2:144-54.
13. Moreno PR, Murcia AM, Palacios IF. Coronary composition and macrophage infiltration in atherectomy specimens from patients with diabetes mellitus. Circulation 2000;102:2180-4.
14. Beckman JA, Creager MA, Libby P. Diabetes and atherosclerosis - Epidemiology, pathophysiology and management. JAMA 2002;287:2570-81.
15. Carter AM. Inflammation, thrombosis and acute coronary syndromes. Diabetes Vasc Dis Res 2005;2:113-21.
16. Marchant B, Umachandran V, Stevenson R, Kopelman PG, Timmis AD. Silent myocardial ischemia: role of subclinical neuropathy in patients with and without diabetes. J Am Coll Cardiol 1993;22:1433-7.
17. Mak KH, Moliterno DJ, Granger CB, Miller DP, White HD, Wilcox RG, et al. Influence of diabetes mellitus on clinical outcome in the thrombolytic era of acute myocardial infarction. GUSTO-I Investigators. Global Utilization of Streptokinase and Tissue plasminogen activator for Occluded coronary arteries. J Am Coll Cardiol 1997;30:171-9.
18. Trichon BH, Roe MT. Acute coronary syndromes and diabetes mellitus. Diabetes Vascul Dis Res 2004;1:23-32.
19. Malmberg K, Yusuf S, Gerstein HC, Brown J, Zhao F, Hunt D, et al. Impact of diabetes on long-term prognosis in patients with unstable angina and non-Q-wave myocardial infarction: results of the OASIS (Organization to Assess Strategies for Ischemic Syndromes) Registry. Circulation 2000;102:1014-9.
20. FRagmin and Fast Revascularisation during Instability in Coronary artery disease (FRISC II) Investigators. Invasive compared with non-invasive treatment in unstable coronary-artery disease: FRISC II prospective randomised multicentre study. Lancet 1999;354:708-15.
21. McGuire DK, Emanuelsson H, Granger CB, Magnus Ohman E, Moliterno DJ, White HD, et al. Influence of Diabetes mellitus on clinical outcomes across the spectrum of acute coronary syndromes: findings from the GUSTO-IIb study. Eur Heart J 2000;21:1750-8.
22. Hildebrandt P. Diabetic patients and acute coronary syndromes. Eur Heart J 2001;22:887-8.
23. DIGAMI-I Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): effects on mortality at 1 year. J Am Coll Cardiol 1995;26(1):57-65.
24. Svensson AM, McGuire DK, Abrahamsson P, Dellborg M. Association between hyper- and hypoglycemia and 2-year all-cause mortality risk in diabetic patients with acute coronary events. Eur Heart J 2005;26:1255-61.
25. Malmberg K, Ryden L, Wedel H, Birkeland K, Bootsma A, Dickstein K, et al, for the DIGAMI-II investigators. DIGAMI-II Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity. Eur Heart J 2005;26(7):650-61.
26. The CREATE-ECLA Trial Group Investigators. Effect of glucose- insulinpotassium infusion on mortality in patients with acute ST-segment elevation myocardial infarction. JAMA 2005;293:437-46.
27. van der Horst IC, Zijlstra F, van't Hof AW, Doggen CJ, de Boer MJ, Suryapranata H, et al.; Zwolle Infarct Study Group. Glucose-insulin-potassium infusion in patients treated with primary angioplasty for acute myocardial infarction: the glucose insulin potassium study: a randomized trial. J Am Coll Cardiol 2003;42:784-91.
28. Fibrinolytic Therapy Trialists' (FTT) Collaborative Group. Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Lancet 1994;343:311-22.
29. Mehta SR, Cannon CP, Fox KAA, Wallentin L, Boden WE, Spacek R, et al. Routine vs. selective invasive strategies in patients with acute coronary syndromes a collaborative meta-analysis of randomized trials. JAMA 2005;293(23):2908-17.
30. Cannon CP, Weintraub WS, Demopoulos LA, Vicari R, Frey MJ, Lakkis N, et al.; TACTICS (Treat Angina with Aggrastat and Determine Cost of Therapy with an Invasive or Conservative Strategy) - Thrombolysis in Myocardial Infarction 18 Investigators. Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban. N Engl J Med 2001;344(25):1879-87.
31. Roffi M, Chew DP, Mukherjee D, Bhatt DL, White JA, Heeschen C, et al. Platelet glycoprotein IIb/IIIa inhibitors reduce mortality in diabetic patients with non-ST-segmentelevation acute coronary syndromes. Circulation 2001; 104:2767-71.
32. Yusuf S, Zhao F, Mehta SR, Chrolavicius S, Tognoni G, Fox KK; Clopidogrel in Unstable Angina to Prevent Recurrent Events Trial Investigators. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med 2001;345:494-502.
33. Malmberg K, Herlltz J, Hjalmarson A, Ryden L. Effects of metoprolol on mortality and late infarction in diabetics with suspected acute myocardial infarction. Retrospective data from two large studies. Eur Heart J 1989;10:423-8.
34. Kjekshus J, Gilpin E, Cali G, Blackey AR, Henning H, Ross J Jr. Diabetic patients and b-blockers after acute myocardial infarction. Eur Heart J 1990;11:43-50.
35. ACE Inhibitor Myocardial Infarction Collaborative Group. Indications for ACE inhibitors in the early treatment of acute myocardial infarction: systematic overview of individual data from 100,000 patients in randomized trials. ACE Inhibitor Myocardial Infarction Collaborative Group. Circulation 1998;97:2202-12.
36. Schwartz GG, Olsson AG, Ezekowitz MD, Ganz P, Oliver MF, Waters D, et al.; Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) Study Investigators. Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial. JAMA 2001;285:1711-8.
37. Kinlay S, Schwartz GG, Olsson AG, Rifai N, Leslie SJ, Sasiela WJ, et al.; Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering Study Investigators. High-dose atorvastatin enhances the decline in inflammatory markers in patients with acute coronary syndromes in the MIRACL study. Circulation 2003;108:1560-6.
38. Cannon CP, Braunwald E, McCabe CH, Rader DJ, Rouleau JL, Belder R, et al.; Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 Investigators. Intensive versus moderate lipid lowering with statins after acute coronary syndromes. N Engl J Med 2004;350:1495-504.
39. Sabatine MS, Cannon CP, Gibson CM, Lopez-Sendon JL, Montalescot G, Theroux P, et al.; CLARITY-TIMI 28 Investigators. Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation. N Engl J Med 2005;352:1179-89.
40. Norhammara A, Malmberga K, Rydena L, Tornvalla P, Stenestrandb U, Wallentinc L, for the Register of Information and Knowledge about Swedish Heart Intensive Care Admissions (RIKS-HIA). Under utilisation of evidence-based treatment partially explains for the unfavourable prognosis in diabetic patients with acute myocardial infarction. Eur Heart J 2003;24:838-44.
41. Brogan GX, Peterson ED, Mulgund J, Bhatt D, Ohman EM, Gibler WB, et al. Treatment disparities in the care of patients with and without diabetes presenting with non-ST-segment elevation acute coronary syndromes. Diabetes Care 2006;29:9-14.
42. Pfeffer MA, Moye LA, Braunwald E, Basta L, Brown EJ Jr, Cuddy TE, et al. Selection bias in the use of thrombolytic therapy in acute myocardial infarction. The SAVE Investigators. JAMA 1991;266:528-32.
43. Barron HV, Bowlby LJ, Breen T, Rogers WJ, Canto JG, Zhang Y, et al. Use of reperfusion therapy for acute myocardial infarction in the United States: data from the National Registry of Myocardial Infarction 2. Circulation 1998;97:1150-6.
44. Collet JP, Montalescot G. The acute reperfusion management of STEMI in patients with impaired glucose tolerance and type 2 diabetes Diabetes Vascul Dis Res 2005;2(3):136-43.
45. Chowdhury TA, Lasker SS, Dyer PH. Comparison of secondary prevention measures after myocardial infarction in subjects with and without diabetes mellitus. J Int Med 1999;245:565-70.